×
About 135 results

ALLMedicine™ Transjugular Liver Biopsy Center

Research & Reviews  51 results

Safety, Feasibility, Yield, Diagnostic and Prognostic Implications of Transjugular Live...
https://doi.org/10.1097/MPG.0000000000003249
Journal of Pediatric Gastroenterology and Nutrition; Lal BB, Sood V et. al.

Jul 27th, 2021 - The objectives of the study were to evaluate the indications, feasibility, complications and clinical implications of transjugular liver biopsy (TJLB) in children. Data of all TJLB performed in children less than 18 years old was retrieved from th...

Accuracy and Safety of 1,055 Transjugular Liver Biopsies in Postliver Transplant Patients.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140774
Clinical and Translational Gastroenterology; Lee EW, Sue MJ et. al.

May 22nd, 2021 - The purpose of this study was to investigate the rates of complications and diagnostic yield of transjugular liver biopsy (TJLB) in deceased donor liver transplant (DDLT) recipients. From January 2009 to December 2019, 1,055 TJLBs were performed i...

The Role of Physician-Driven Device Preference in the Cost Variation of Common Interven...
https://doi.org/10.1016/j.jvir.2021.01.275
Journal of Vascular and Interventional Radiology : JVIR; Shivakumar V, Bundorf MK et. al.

Mar 31st, 2021 - To analyze the impact of physician-specific equipment preference on cost variation for procedures typically performed by interventional radiologists at a tertiary care academic hospital. From October 2017 to October 2019, data on all expendable it...

Transjugular liver biopsy for Fontan associated liver disease surveillance: Technique, ...
https://doi.org/10.1016/j.ijcard.2020.11.037
International Journal of Cardiology; Borquez AA, Silva-Sepulveda J et. al.

Dec 6th, 2020 - Fontan associated liver disease (FALD) is attributed to the limitations of the Fontan circulation, resulting in congestive hepatopathy. The technique and outcomes of transjugular liver biopsies (TJLB) in Fontan patients warrant definition as part ...

see more →

Clinicaltrials.gov  3 results

19 Versus 22-Gauge Needle for EUS-LB
https://clinicaltrials.gov/ct2/show/NCT02967991

Nov 8th, 2017 - Chronic liver disorders (CLD) are a major cause of morbidity and mortality for individuals in the US. Though serologic analysis will often lead to a conclusive diagnosis, liver biopsy remains an important method for helping to determine the etiolo...

Peginterferon Alpha-2a Maintenance Therapy for Portal Hypertension in Patients With Hepatitis C
https://clinicaltrials.gov/ct2/show/NCT00252642

Mar 20th, 2017 - Portal hypertension develops in patients with advanced fibrosis and cirrhosis and is the primary driving force leading to complications of cirrhosis, hepatic decompensation and mortality in patients with chronic liver disease. None of the three ma...

Sedation and Analgesia for Transjugular Liver Biopsy: A Randomized Double Blind Placebo Controlled Trial
https://clinicaltrials.gov/ct2/show/NCT00596414

Jan 17th, 2008 - Consecutive patients undergoing transjugular liver biopsy will be randomly assigned to receive either placebo or midazolam (0.02 mg/kg) or 0.02 mg/kg midazolam combined with 1 mg/kg pethidine before the procedure.

see more →